Journal ArticleNPJ Digit Med · October 7, 2025
While large language models (LLMs) hold promise for transforming clinical healthcare, current comparisons and benchmark evaluations of large language models in medicine often fail to capture real-world efficacy. Specifically, we highlight how key discrepan ...
Full textLink to itemCite
Journal ArticleNPJ Digit Med · June 13, 2025
Ambient digital scribing (ADS) tools alleviate clinician documentation burden, reducing burnout and enhancing efficiency. As AI-driven ADS tools integrate into clinical workflows, robust governance is essential for ethical and secure deployment. This study ...
Full textLink to itemCite
Journal ArticleJ Am Med Inform Assoc · April 1, 2025
OBJECTIVES: Large language models (LLMs) are increasingly utilized in healthcare, transforming medical practice through advanced language processing capabilities. However, the evaluation of LLMs predominantly relies on human qualitative assessment, which i ...
Full textLink to itemCite
ConferenceEmnlp 2025 2025 Conference on Empirical Methods in Natural Language Processing Findings of Emnlp 2025 · January 1, 2025
People are increasingly seeking healthcare information from large language models (LLMs) via interactive chatbots, yet the nature and inherent risks of these conversations remain largely unexplored. In this paper, we filter large-scale conversational AI da ...
Full textCite
Journal ArticleJ Am Med Inform Assoc · June 20, 2024
OBJECTIVE: Leverage electronic health record (EHR) audit logs to develop a machine learning (ML) model that predicts which notes a clinician wants to review when seeing oncology patients. MATERIALS AND METHODS: We trained logistic regression models using n ...
Full textLink to itemCite
Journal ArticleJCO Clin Cancer Inform · May 2021
PURPOSE: Key oncology end points are not routinely encoded into electronic medical records (EMRs). We assessed whether natural language processing (NLP) can abstract treatment discontinuation rationale from unstructured EMR notes to estimate toxicity incid ...
Full textLink to itemCite
Journal ArticleBioinformatics · July 1, 2018
MOTIVATION: The use of drug combinations, termed polypharmacy, is common to treat patients with complex diseases or co-existing conditions. However, a major consequence of polypharmacy is a much higher risk of adverse side effects for the patient. Polyphar ...
Full textLink to itemCite
ConferencePac Symp Biocomput · 2018
Discovering disease pathways, which can be defined as sets of proteins associated with a given disease, is an important problem that has the potential to provide clinically actionable insights for disease diagnosis, prognosis, and treatment. Computational ...
Link to itemCite